Routine: IBDEI2UA

IBDEI2UA ; ; 04-FEB-2020

 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020

 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y

Q Q

 ;;^UTILITY(U,$J,358.3,45291,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,45291,1,3,0)

 ;;=3^Obesity, unspecified

 ;;^UTILITY(U,$J,358.3,45291,1,4,0)

 ;;=4^E66.9

 ;;^UTILITY(U,$J,358.3,45291,2)

 ;;=^5002832

 ;;^UTILITY(U,$J,358.3,45292,0)

 ;;=E74.39^^172^2262^25

 ;;^UTILITY(U,$J,358.3,45292,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,45292,1,3,0)

 ;;=3^Intestinal carbohydrate absorption disorder, other

 ;;^UTILITY(U,$J,358.3,45292,1,4,0)

 ;;=4^E74.39

 ;;^UTILITY(U,$J,358.3,45292,2)

 ;;=^5002928

 ;;^UTILITY(U,$J,358.3,45293,0)

 ;;=E78.1^^172^2262^17

 ;;^UTILITY(U,$J,358.3,45293,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,45293,1,3,0)

 ;;=3^Hyperglyceridemia, pure

 ;;^UTILITY(U,$J,358.3,45293,1,4,0)

 ;;=4^E78.1

 ;;^UTILITY(U,$J,358.3,45293,2)

 ;;=^101303

 ;;^UTILITY(U,$J,358.3,45294,0)

 ;;=E78.5^^172^2262^20

 ;;^UTILITY(U,$J,358.3,45294,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,45294,1,3,0)

 ;;=3^Hyperlipidemia,Unspec

 ;;^UTILITY(U,$J,358.3,45294,1,4,0)

 ;;=4^E78.5

 ;;^UTILITY(U,$J,358.3,45294,2)

 ;;=^5002969

 ;;^UTILITY(U,$J,358.3,45295,0)

 ;;=E86.0^^172^2262^13

 ;;^UTILITY(U,$J,358.3,45295,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,45295,1,3,0)

 ;;=3^Dehydration

 ;;^UTILITY(U,$J,358.3,45295,1,4,0)

 ;;=4^E86.0

 ;;^UTILITY(U,$J,358.3,45295,2)

 ;;=^332743

 ;;^UTILITY(U,$J,358.3,45296,0)

 ;;=E87.1^^172^2262^21

 ;;^UTILITY(U,$J,358.3,45296,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,45296,1,3,0)

 ;;=3^Hypo-osmolality & hyponatremia

 ;;^UTILITY(U,$J,358.3,45296,1,4,0)

 ;;=4^E87.1

 ;;^UTILITY(U,$J,358.3,45296,2)

 ;;=^5003019

 ;;^UTILITY(U,$J,358.3,45297,0)

 ;;=E87.5^^172^2262^18

 ;;^UTILITY(U,$J,358.3,45297,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,45297,1,3,0)

 ;;=3^Hyperkalemia

 ;;^UTILITY(U,$J,358.3,45297,1,4,0)

 ;;=4^E87.5

 ;;^UTILITY(U,$J,358.3,45297,2)

 ;;=^60041

 ;;^UTILITY(U,$J,358.3,45298,0)

 ;;=E87.6^^172^2262^23

 ;;^UTILITY(U,$J,358.3,45298,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,45298,1,3,0)

 ;;=3^Hypokalemia

 ;;^UTILITY(U,$J,358.3,45298,1,4,0)

 ;;=4^E87.6

 ;;^UTILITY(U,$J,358.3,45298,2)

 ;;=^60610

 ;;^UTILITY(U,$J,358.3,45299,0)

 ;;=E87.70^^172^2262^14

 ;;^UTILITY(U,$J,358.3,45299,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,45299,1,3,0)

 ;;=3^Fluid overload, unspecified

 ;;^UTILITY(U,$J,358.3,45299,1,4,0)

 ;;=4^E87.70

 ;;^UTILITY(U,$J,358.3,45299,2)

 ;;=^5003023

 ;;^UTILITY(U,$J,358.3,45300,0)

 ;;=E78.00^^172^2262^15

 ;;^UTILITY(U,$J,358.3,45300,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,45300,1,3,0)

 ;;=3^Hypercholesterolemia,Pure

 ;;^UTILITY(U,$J,358.3,45300,1,4,0)

 ;;=4^E78.00

 ;;^UTILITY(U,$J,358.3,45300,2)

 ;;=^5138435

 ;;^UTILITY(U,$J,358.3,45301,0)

 ;;=E78.49^^172^2262^19

 ;;^UTILITY(U,$J,358.3,45301,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,45301,1,3,0)

 ;;=3^Hyperlipidemia,Other

 ;;^UTILITY(U,$J,358.3,45301,1,4,0)

 ;;=4^E78.49

 ;;^UTILITY(U,$J,358.3,45301,2)

 ;;=^5157299

 ;;^UTILITY(U,$J,358.3,45302,0)

 ;;=F02.80^^172^2263^8

 ;;^UTILITY(U,$J,358.3,45302,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,45302,1,3,0)

 ;;=3^Dementia in oth diseases w/o behavrl disturb

 ;;^UTILITY(U,$J,358.3,45302,1,4,0)

 ;;=4^F02.80

 ;;^UTILITY(U,$J,358.3,45302,2)

 ;;=^5003048

 ;;^UTILITY(U,$J,358.3,45303,0)

 ;;=F02.81^^172^2263^7

 ;;^UTILITY(U,$J,358.3,45303,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,45303,1,3,0)

 ;;=3^Dementia in oth diseases w/ behavioral disturb

 ;;^UTILITY(U,$J,358.3,45303,1,4,0)

 ;;=4^F02.81

--- Routine Detail   --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2UA   3785     printed  Feb 19, 2025@00:02:24                                                                                                                                                                                                    Page 2

IBDEI2UA  ; ; 04-FEB-2020

 +1       ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020

 +2        if 'DIFQR(358.3)

               QUIT

           FOR I=1:2

               SET X=$TEXT(Q+I)

               if X=""

                   QUIT

               SET Y=$EXTRACT($TEXT(Q+I+1),4,999)

               SET X=$EXTRACT(X,4,999)

               if $ASCII(Y)=126

                   SET I=I+1

                   SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)

               if $ASCII(Y)=61

                   SET Y=$EXTRACT(Y,2,999)

               XECUTE NO

              IF '$TEST

                   SET @X=Y

Q          QUIT

 +1       ;;^UTILITY(U,$J,358.3,45291,1,0)

 +2       ;;=^358.31IA^4^2

 +3       ;;^UTILITY(U,$J,358.3,45291,1,3,0)

 +4       ;;=3^Obesity, unspecified

 +5       ;;^UTILITY(U,$J,358.3,45291,1,4,0)

 +6       ;;=4^E66.9

 +7       ;;^UTILITY(U,$J,358.3,45291,2)

 +8       ;;=^5002832

 +9       ;;^UTILITY(U,$J,358.3,45292,0)

 +10      ;;=E74.39^^172^2262^25

 +11      ;;^UTILITY(U,$J,358.3,45292,1,0)

 +12      ;;=^358.31IA^4^2

 +13      ;;^UTILITY(U,$J,358.3,45292,1,3,0)

 +14      ;;=3^Intestinal carbohydrate absorption disorder, other

 +15      ;;^UTILITY(U,$J,358.3,45292,1,4,0)

 +16      ;;=4^E74.39

 +17      ;;^UTILITY(U,$J,358.3,45292,2)

 +18      ;;=^5002928

 +19      ;;^UTILITY(U,$J,358.3,45293,0)

 +20      ;;=E78.1^^172^2262^17

 +21      ;;^UTILITY(U,$J,358.3,45293,1,0)

 +22      ;;=^358.31IA^4^2

 +23      ;;^UTILITY(U,$J,358.3,45293,1,3,0)

 +24      ;;=3^Hyperglyceridemia, pure

 +25      ;;^UTILITY(U,$J,358.3,45293,1,4,0)

 +26      ;;=4^E78.1

 +27      ;;^UTILITY(U,$J,358.3,45293,2)

 +28      ;;=^101303

 +29      ;;^UTILITY(U,$J,358.3,45294,0)

 +30      ;;=E78.5^^172^2262^20

 +31      ;;^UTILITY(U,$J,358.3,45294,1,0)

 +32      ;;=^358.31IA^4^2

 +33      ;;^UTILITY(U,$J,358.3,45294,1,3,0)

 +34      ;;=3^Hyperlipidemia,Unspec

 +35      ;;^UTILITY(U,$J,358.3,45294,1,4,0)

 +36      ;;=4^E78.5

 +37      ;;^UTILITY(U,$J,358.3,45294,2)

 +38      ;;=^5002969

 +39      ;;^UTILITY(U,$J,358.3,45295,0)

 +40      ;;=E86.0^^172^2262^13

 +41      ;;^UTILITY(U,$J,358.3,45295,1,0)

 +42      ;;=^358.31IA^4^2

 +43      ;;^UTILITY(U,$J,358.3,45295,1,3,0)

 +44      ;;=3^Dehydration

 +45      ;;^UTILITY(U,$J,358.3,45295,1,4,0)

 +46      ;;=4^E86.0

 +47      ;;^UTILITY(U,$J,358.3,45295,2)

 +48      ;;=^332743

 +49      ;;^UTILITY(U,$J,358.3,45296,0)

 +50      ;;=E87.1^^172^2262^21

 +51      ;;^UTILITY(U,$J,358.3,45296,1,0)

 +52      ;;=^358.31IA^4^2

 +53      ;;^UTILITY(U,$J,358.3,45296,1,3,0)

 +54      ;;=3^Hypo-osmolality & hyponatremia

 +55      ;;^UTILITY(U,$J,358.3,45296,1,4,0)

 +56      ;;=4^E87.1

 +57      ;;^UTILITY(U,$J,358.3,45296,2)

 +58      ;;=^5003019

 +59      ;;^UTILITY(U,$J,358.3,45297,0)

 +60      ;;=E87.5^^172^2262^18

 +61      ;;^UTILITY(U,$J,358.3,45297,1,0)

 +62      ;;=^358.31IA^4^2

 +63      ;;^UTILITY(U,$J,358.3,45297,1,3,0)

 +64      ;;=3^Hyperkalemia

 +65      ;;^UTILITY(U,$J,358.3,45297,1,4,0)

 +66      ;;=4^E87.5

 +67      ;;^UTILITY(U,$J,358.3,45297,2)

 +68      ;;=^60041

 +69      ;;^UTILITY(U,$J,358.3,45298,0)

 +70      ;;=E87.6^^172^2262^23

 +71      ;;^UTILITY(U,$J,358.3,45298,1,0)

 +72      ;;=^358.31IA^4^2

 +73      ;;^UTILITY(U,$J,358.3,45298,1,3,0)

 +74      ;;=3^Hypokalemia

 +75      ;;^UTILITY(U,$J,358.3,45298,1,4,0)

 +76      ;;=4^E87.6

 +77      ;;^UTILITY(U,$J,358.3,45298,2)

 +78      ;;=^60610

 +79      ;;^UTILITY(U,$J,358.3,45299,0)

 +80      ;;=E87.70^^172^2262^14

 +81      ;;^UTILITY(U,$J,358.3,45299,1,0)

 +82      ;;=^358.31IA^4^2

 +83      ;;^UTILITY(U,$J,358.3,45299,1,3,0)

 +84      ;;=3^Fluid overload, unspecified

 +85      ;;^UTILITY(U,$J,358.3,45299,1,4,0)

 +86      ;;=4^E87.70

 +87      ;;^UTILITY(U,$J,358.3,45299,2)

 +88      ;;=^5003023

 +89      ;;^UTILITY(U,$J,358.3,45300,0)

 +90      ;;=E78.00^^172^2262^15

 +91      ;;^UTILITY(U,$J,358.3,45300,1,0)

 +92      ;;=^358.31IA^4^2

 +93      ;;^UTILITY(U,$J,358.3,45300,1,3,0)

 +94      ;;=3^Hypercholesterolemia,Pure

 +95      ;;^UTILITY(U,$J,358.3,45300,1,4,0)

 +96      ;;=4^E78.00

 +97      ;;^UTILITY(U,$J,358.3,45300,2)

 +98      ;;=^5138435

 +99      ;;^UTILITY(U,$J,358.3,45301,0)

 +100     ;;=E78.49^^172^2262^19

 +101     ;;^UTILITY(U,$J,358.3,45301,1,0)

 +102     ;;=^358.31IA^4^2

 +103     ;;^UTILITY(U,$J,358.3,45301,1,3,0)

 +104     ;;=3^Hyperlipidemia,Other

 +105     ;;^UTILITY(U,$J,358.3,45301,1,4,0)

 +106     ;;=4^E78.49

 +107     ;;^UTILITY(U,$J,358.3,45301,2)

 +108     ;;=^5157299

 +109     ;;^UTILITY(U,$J,358.3,45302,0)

 +110     ;;=F02.80^^172^2263^8

 +111     ;;^UTILITY(U,$J,358.3,45302,1,0)

 +112     ;;=^358.31IA^4^2

 +113     ;;^UTILITY(U,$J,358.3,45302,1,3,0)

 +114     ;;=3^Dementia in oth diseases w/o behavrl disturb

 +115     ;;^UTILITY(U,$J,358.3,45302,1,4,0)

 +116     ;;=4^F02.80

 +117     ;;^UTILITY(U,$J,358.3,45302,2)

 +118     ;;=^5003048

 +119     ;;^UTILITY(U,$J,358.3,45303,0)

 +120     ;;=F02.81^^172^2263^7

 +121     ;;^UTILITY(U,$J,358.3,45303,1,0)

 +122     ;;=^358.31IA^4^2

 +123     ;;^UTILITY(U,$J,358.3,45303,1,3,0)

 +124     ;;=3^Dementia in oth diseases w/ behavioral disturb

 +125     ;;^UTILITY(U,$J,358.3,45303,1,4,0)

 +126     ;;=4^F02.81

IBDEI2UA.m